Community Invited to Explore Opportunities at Nursing and Allied Health Open House

Translate to Spanish or other 102 languages!

South Texas College’s Nursing and Allied Health campus will be hosting its open house March 30 from 9 a.m. to 1 p.m.
South Texas College’s Nursing and Allied Health campus will be hosting its open house March 30 from 9 a.m. to 1 p.m.

Mega Doctor News

- Advertisement -

McAllen, Texas – South Texas College’s Nursing and Allied Health Campus will be hosting its open house March 30.

The open house provides an opportunity for the public to tour the different facilities within the NAH campus, as well as explore the many career pathways in the medical field.

Advisors will be on site to discuss information regarding the Texas Success Initiative Assessment (TSI). Those interested can also register for the fall 2019 semester.

- Advertisement -

Department Chair for Pharmacy Technology at STC, Dr. Theresa Garza expressed the importance of attending the open house.

“The goal is to really make sure that attendees have a chance to get some face to face advising time,” said Garza. “We want to get them started on the right path.”

The open house will take place Saturday, March 30, from 9 a.m. to 1 p.m. at the STC Nursing and Allied Campus located at 1101 E. Vermont McAllen, TX.

For more information regarding the open house at the Nursing and Allied Health campus, please contact Dr. Theresa Garza at 956-872-3102

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

STHS McAllen Launches Naming Contest for Advanced Surgical Robot

Using advanced robotic technology to assist surgeons in performing complex procedures with enhanced precision, dexterity and control, robotic surgery represents one of the most significant advancements in modern medicine.

DHR Health Raises Over $520K at 20th “Fishing for Hope” Event

DHR Health made a big splash at the 20th Annual “Fishing for Hope” Tournament, held on August 22 at Jim’s Pier in South Padre Island, raising an impressive grand total of $524,130.

FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancer

The U.S. Food and Drug Administration approved Rasonque (daraxonrasib), a RAS inhibitor for the most common form of pancreatic cancer—delivering a new treatment option to patients with advanced pancreatic cancer months ahead of schedule. 

STHS Behavioral Marks Suicide Prevention Month with Community Chalk Event

Every 11 minutes, someone in the United States dies by suicide, according to the Centers for Disease Control and Prevention (CDC), making it one of the nation's leading causes of death.
- Advertisement -